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Summary. To evaluate the possible antigoitrogenic 
effect of somatostatin, the influence of long-acting 
somatostatin analog - octreotide - on experimental goiter 
developed in rats treated with propylthiouracil was 
examined. Goiter formation was assessed by measure- 
ment of the main histological compartments of the 
thyroid as well as by morphometric analysis of the 
vascularization and blood supply of the gland. Although 
treatment with octreotide did not prevent the goiter 
formation, it clearly reduced blood supply and vascu- 
larization of the thyroid and counteracted propylthio- 
uracil-induced increase in the relative volume of 
follicular epithelium. To conclude, the somatostatin 
analog - octreotide - is effective in reduction of goiter 
vascularisation. This finding provides a rationale for the 
clinical trials of the treatment of hypewascular goiter by 
somatostatin analogs. 
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of human thyroid cancer cell lines (Hoelting et al., 
1996). The presence of somatostatin receptors has been 
shown in human thyroid cancers in vitro (Ain and 
Taylor, 1994) as well as in vivo (Postema et al., 1996). 
The binding of radiolabeled octreotide has also been 
found in normal and goitrous thyroid gland in human 
subjects (Becker et al., 1995). These data suggest that 
somatostatin may counteract the goiter formation, since 
the latter depend on increased proliferation of thyrocytes 
and is often connected with enhanced TSH secretion. It 
is also worth recalling that goitrogenesis is accompanied 
by enhanced neo-vascularization, and somatostatin 
exhibits an anti-angiogenetic activity (Barrie et al., 
1993). To prove the possibility that somatostatin may 
counteract the goitrogenesis, we have evaluated the 
effect of long-acting somatostatin analog, octreotide 
(SMS), on experimental goiter developed in rats treated 
with propylthiouracil (PTU). PTU-induced goiter is a 
commonly used model of the experimental goiter in 
rodents (Denef et al., 1989) 
Materials and methods 
Introduction 
Somatostatin is one of the important physiological 
regulators of thyrotropin (TSH) secretion. In addition to 
the effect exerted at the pituitary level, somatostatin also 
acts at the level of the thyroid gland. It has been found 
that somatostatin is able to inhibit TSH-induced 
secretion of thyroid hormones (Loos et al., 1977; Ahren 
et al., 1978). In our laboratory we have found that 
somatostatin directly suppresses the basal and TSH- 
stimulated mitotic activity of the organ-cultured rat 
thyroid lobes (zerek-Melefi et al., 1987). The in vitro 
antiproliferative effects of somatostatin have also been 
shown in respect to human thyrocytes (degli Umberti et 
al., 1991) as well as to the rat thyroid follicular cell line 
FRTLS (Tsuzaki and Moses, 1990). Somatostatin analog 
- octreotide - has been found to inhibit the proliferation 
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llventy-four male Wistar rats were used, weighing 
170-240 g each at the beginning of the experiment. The 
animals were divided into 3 equal groups and fed with 
standard laboratory diet. Propylthiouracil (6-n-propyl-2- 
thiouracil [Sigma]) was administered as a 0.1% solution 
in drinking water in 2 groups. Since the 3rd day of PTU 
administration the rats were injected subcutaneously 
either with 10 p g  of octreotide (Sandoz) or with 0.9% 
NaCl solution every 12 hours. After 8 days of the 
experiment the animals were weighed and sacrificed 
by prolonged ether anaesthesia and the thyroids 
were carefully collected and weighed. After proper 
histological procedures the paraffin sections (8 p m  
thick) were subjected to morphometric analysis, which 
included assessment of the vascularization and blood 
supply of the thyroids as well as the measurement of the 
relative volumes of thyroid compartments. 
The analysis of the vascularization and blood supply 
of the thyroid tissue was carried out with use of the 
digital image analyzer (IBAS for Windows, KONTRON, 



